- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07588893
Buerger-Allen Exercises and Peripheral Circulation in Sedentary Office Workers (BAE-CIRC)
Acute Effects of Buerger-Allen Exercises on Lower Extremity Circulatory Parameters in Sedentary Office Workers: A Single-Group Pretest-Posttest Clinical Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Sedentary behavior and prolonged sitting are associated with impaired venous return, reduced peripheral blood flow, endothelial dysfunction, and increased cardiovascular risk. Office workers who remain seated for extended periods may experience lower extremity discomfort, edema, and early circulatory impairment.
Buerger-Allen exercises are position-based therapeutic exercises that involve sequential elevation, dependency, and horizontal rest of the lower limbs. These exercises are designed to promote arterial inflow, facilitate venous return, and enhance tissue perfusion without requiring specialized equipment. Previous studies have demonstrated beneficial effects in patients with peripheral vascular disease and diabetes, but evidence regarding their acute effects in healthy sedentary adults is limited.
This study will use a quasi-experimental single-group pretest-posttest design to investigate the immediate effects of Buerger-Allen exercises on lower extremity circulation in sedentary office workers. A total of 35 participants aged 18 to 45 years will be recruited from Istanbul Gelisim University. All participants will complete a standardized 20-minute Buerger-Allen exercise protocol.
Primary outcome measures will include skin surface temperature assessed with infrared thermometry, capillary refill time, ankle-brachial index, peripheral oxygen saturation, and heart rate. Measurements will be performed at baseline, immediately after the intervention, and 10 minutes after the intervention.
The study is expected to provide evidence regarding the effectiveness of a simple and low-cost physiotherapy intervention for improving peripheral circulation and preventing the adverse vascular effects associated with prolonged sedentary behavior.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Busenur KARAGÖZ, MSc
- Numéro de téléphone: +90 534 062 71 24
- E-mail: buse.nur97e@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Gökay ÇAKIROĞLU, PT
- Numéro de téléphone: +90 542 519 42 55
- E-mail: gcakiroglu@gelisim.edu.tr
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- Istanbul Gelisim University
-
Contact:
- Busenur KARAGÖZ, MSc
- Numéro de téléphone: +90 534 062 71 24
- E-mail: buse.nur97e@gmail.com
-
Contact:
- Gökay ÇAKIROĞLU, PT
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Healthy sedentary office workers
- Age between 18 and 45 years
- Sitting for at least 6 hours per day for work-related activities
- Not meeting regular physical activity recommendations
- Willing to participate voluntarily and provide written informed consent
Exclusion Criteria:
- History of peripheral arterial disease, deep vein thrombosis, or other vascular disorders
- Cardiovascular, neurological, or musculoskeletal conditions that may affect lower extremity circulation or prevent exercise participation
- Diabetes mellitus
- Current smoking
- Pregnancy
- Use of medications that may significantly affect peripheral circulation
- Lower extremity injury or surgery within the previous 6 months
- Participation in regular structured exercise programs
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Buerger-Allen Exercise Group
Participants will perform a single standardized 20-minute Buerger-Allen exercise session.
Lower extremity circulatory parameters will be assessed before the intervention, immediately after the intervention, and 10 minutes after the intervention.
|
The intervention consists of a standardized Buerger-Allen exercise protocol involving three sequential positions: (1) elevation of the lower limbs above heart level to facilitate venous return, (2) dependency of the lower limbs to promote arterial blood flow, and (3) horizontal supine rest to stabilize circulation.
The complete exercise session lasts approximately 20 minutes and is performed once.
Lower extremity circulatory parameters are assessed at baseline, immediately after the intervention, and 10 minutes after the intervention.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Skin Surface Temperature
Délai: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Skin surface temperature measured with an infrared thermometer in degrees Celsius (°C).
Higher values indicate increased peripheral blood flow and tissue perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Capillary Refill Time
Délai: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Capillary refill time measured in seconds.
Shorter times indicate improved peripheral microcirculation and tissue perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Ankle-Brachial Index (ABI)
Délai: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Ratio of ankle to brachial systolic blood pressure used to assess lower extremity arterial circulation.
Higher values within the normal range indicate better arterial perfusion.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Peripheral Oxygen Saturation (SpO₂)
Délai: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Oxygen saturation measured by pulse oximetry and expressed as a percentage (%).
Higher values indicate improved peripheral oxygenation.
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
|
Heart Rate
Délai: Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Heart rate measured by pulse oximetry and expressed in beats per minute (bpm).
|
Baseline, Immediately After Intervention, and 10 Minutes After Intervention
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Busenur KARAGÖZ, MSc, Istanbul Gelisim University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IGU-FTR-BAE-2026-001
- 2209A-2025Fall-Submitted (Autre identifiant: The Scientific and Technological Research Council of Türkiye (TUBITAK))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .